Board Change • Jul 31
High number of new directors Independent Director Tim Childs was the last director to join the board, commencing their role in 2022. Reported Earnings • Jun 02
Second quarter 2022 earnings released: CA$0.058 loss per share (vs CA$0.06 loss in 2Q 2021) Second quarter 2022 results: CA$0.058 loss per share (up from CA$0.06 loss in 2Q 2021). Revenue: CA$2.02m (down 7.6% from 2Q 2021). Net loss: CA$8.32m (loss narrowed 3.1% from 2Q 2021). Over the last 3 years on average, earnings per share has fallen by 37% per year but the company’s share price has fallen by 60% per year, which means it is performing significantly worse than earnings. 공시 • May 07
MPX International Corporation, Annual General Meeting, Jul 15, 2022 MPX International Corporation, Annual General Meeting, Jul 15, 2022. Board Change • Apr 27
Less than half of directors are independent There are 5 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 5 new directors. 4 experienced directors. No highly experienced directors. 2 independent directors (4 non-independent directors). Chairman, President & CEO William Boyes is the most experienced director on the board, commencing their role in 2018. Independent Director Robert Petch was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors. Reported Earnings • Mar 04
First quarter 2022 earnings: Revenues and EPS in line with analyst expectations First quarter 2022 results: CA$0.03 loss per share (down from CA$0.016 loss in 1Q 2021). Revenue: CA$1.56m (down 19% from 1Q 2021). Net loss: CA$4.25m (loss widened 88% from 1Q 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 45% per year but the company’s share price has fallen by 62% per year, which means it is performing significantly worse than earnings. Reported Earnings • Feb 02
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Full year 2021 results: CA$0.19 loss per share (up from CA$0.29 loss in FY 2020). Revenue: CA$7.21m (up 127% from FY 2020). Net loss: CA$26.6m (loss narrowed 35% from FY 2020). Revenue was in line with analyst estimates. Reported Earnings • Sep 02
Third quarter 2021 earnings released: CA$0.013 loss per share (vs CA$0.037 loss in 3Q 2020) The company reported a solid third quarter result with reduced losses, improved revenues and improved control over expenses. Third quarter 2021 results: Revenue: CA$1.78m (up 93% from 3Q 2020). Net loss: CA$1.89m (loss narrowed 65% from 3Q 2020). Reported Earnings • May 30
Second quarter 2021 earnings released: CA$0.06 loss per share (vs CA$0.018 loss in 2Q 2020) The company reported a decent second quarter result with improved revenues, although losses increased and control over costs was weaker. Second quarter 2021 results: Revenue: CA$2.19m (up 174% from 2Q 2020). Net loss: CA$8.59m (loss widened 240% from 2Q 2020). Executive Departure • Apr 17
Independent Director has left the company On the 16th of April, Randall Stafford's tenure as Independent Director ended after 2.2 years in the role. We don't have any record of a personal shareholding under Randall's name. A total of 2 executives have left over the last 12 months. Reported Earnings • Mar 03
First quarter 2021 earnings released: CA$0.016 loss per share (vs CA$0.033 loss in 1Q 2020) The company reported a solid first quarter result with reduced losses, improved revenues and improved control over expenses. First quarter 2021 results: Revenue: CA$1.91m (up 210% from 1Q 2020). Net loss: CA$2.26m (loss narrowed 49% from 1Q 2020). Is New 90 Day High Low • Feb 10
New 90-day high: CA$0.25 The company is up 150% from its price of CA$0.10 on 11 November 2020. The Canadian market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Pharmaceuticals industry, which is up 92% over the same period. Reported Earnings • Feb 01
Full year 2020 earnings released: CA$0.29 loss per share (vs CA$0.13 loss in FY 2019) Full year 2020 results: Net loss: CA$41.0m (loss widened 338% from FY 2019). 공시 • Oct 20
MPX International Corporation Appoints Jeremy Blumer as Chief Financial Officer MPX International Corporation announced the appointment of Jeremy Blumer as the company's new Chief Financial Officer, effective October 16, 2020, subject to regulatory approval. Mr. Blumer brings over 25 years of financial experience with both public and private companies to the Corporation, including in the cannabis industry as CFO with Quality Green Inc. and Wayland Group Corp. (formerly Maricann Group Inc.). Mr. Blumer was also the Senior Director and Head of Accounting at Blackberry and held senior finance positions with Certicom, Ontario Ambulance Services Co and Pilot Insurance. Reported Earnings • Oct 18
Third quarter earnings released Over the last 12 months the company has reported total losses of CA$15.3m, with losses widening by 103% from the prior year. 공시 • Jun 19
MPX International Corporation announced that it expects to receive CAD 5 million in funding MPX International Corporation (CNSX:MPXI) announced a non-brokered private placement of minimum of 3,000 units for gross proceeds of CAD 4,000,000 and a maximum of 3,700 units for gross proceeds of CAD 5,000,000 on June 18, 2020. Each unit consists of one 12% secured convertible debenture in the principal amount of $1,000.00 (CAD 1,351.3513) and 7,000 common share purchase warrants. The debenture carries a coupon of 12% per annum and will have a maturity date of 24 months from the date of issuance, subject to certain conversion privileges as set forth in a debenture indenture with AST Trust Company (Canada). Each debenture will rank pari passu in right of payment of principal and interest with all other debentures issued under the Offering. The debenture is convertible into common shares of the company at an exercise price of CAD 0.12 per share. Each warrant will entities to the holders to purchase one common shares at CAD 0.20 per share for a period of 24 months. The debentures will be payable quarterly in arrears.
The company may pay a cash placement fee equal to 5% of the aggregate gross proceeds paid by each purchaser of units that are invested in the transaction. In addition, the corporation may issue that number of common share purchase warrants equal to 5% of the aggregate number of common shares underlying the debentures if converted as of the closing date and the warrants issued to purchasers of the units excluding the aggregate number units purchased by investors that participated in the corporation’s equity raise which closed in March 2019. The compensation warrants shall be exercisable at the exercise price for a period of 2 years from the applicable closing date of the offering. The transaction is subject to regulatory and Canadian Securities Exchange approval and may occur in multiple tranches. All securities issued in connection with the transaction will be subject to a statutory four-month and one day hold period. 